Thrombolytic therapy in older patients.

Area of Science:

• Cardiology
• Geriatric Medicine
• Public Health

Background:

• Evidence for reperfusion therapy efficacy in elderly acute myocardial infarction (AMI) patients is limited.
• Older adults represent a significant and growing population with AMI.

Purpose of the Study:

• To compare outcomes of thrombolytic therapy and primary angioplasty versus no reperfusion in older AMI patients.
• To evaluate the impact of reperfusion strategies on short-term and long-term survival in elderly AMI patients.

Main Methods:

• Analysis of a national cohort of Medicare beneficiaries aged 65+ with AMI.
• Comparison of outcomes for patients receiving thrombolytic therapy, primary angioplasty, or no reperfusion therapy.
• Statistical adjustment for demographic, clinical, hospital, and physician factors.

Main Results:

• Primary angioplasty was associated with improved 30-day survival (OR 0.79; 95% CI: 0.66 to 0.94) compared to no therapy.
• Thrombolytic therapy did not show a significant 30-day survival benefit (OR 1.01; 95% CI: 0.94 to 1.09).
• Both thrombolytic therapy (OR 0.84; 95% CI: 0.79 to 0.89) and primary angioplasty (OR 0.71; 95% CI: 0.61 to 0.83) were linked to one-year survival benefits.

Conclusions:

• Both thrombolytic therapy and primary angioplasty are associated with reduced mortality at one year in older AMI patients.
• Primary angioplasty demonstrates a significant survival advantage at 30 days in this population.
• Findings highlight the need for further investigation into optimal reperfusion strategies for elderly patients with AMI.